机译:纤溶酶原激活剂尿激酶(PLAU)中的功能多态性与阿尔茨海默氏病有关
Neurochemistry and Neurogenetics Laboratory Department of Psychiatry and Psychotherapy;
Institute of Pathology;
Department of Medical Statistics and Epidemiology;
Department of Psychiatry and Psychotherapy Technische Universität München (TUM) Ismaningerstr. 22 81675 Munich Germany;
Sir James McCusker Alzheimer's Disease Research Unit Hollywood Private Hospital Perth Western Australia;
Clinica Neurologica Università degli Studi di Brescia Brescia Italy;
Department of Psychiatry and Psychotherapy Friedrich Wilhelms Universität Bonn Germany;
Institute of Epidemiology GSF München-Neuherberg Germany;
Department of Genetic Epidemiology University of Göttingen Germany;
School of Psychiatry and Clinical Neurosciences University of Western Australia Perth Australia;
Institute of Human Genetics University of Giessen Germany;
Institute of Neuropathology University Hospital Muenster Germany;
Alzheimer's and Aging School of Biomedical and Sports Science Edith Cowan University Joondalup Australia and;
Hertie-Institute for Clinical Brain Research Tuebingen Germany;
机译:纤溶酶原激活物尿激酶(PLAU)内的功能多态性与阿尔茨海默氏病有关。
机译:尿激酶型纤溶酶原激活物多态性PLAU_1是意大利阿尔茨海默病人群中APOE-ε4非携带者的危险因素,并且不影响血浆Abeta(1-42)水平。
机译:尿激酶-纤溶酶原激活物(PLAU)基因中的tagSNP与阿尔茨海默氏病和相关的数量性状的关联。
机译:冠状动脉疾病患者的纤溶酶原激活剂抑制剂I(PAI-I)-675 5G / 4G多态性
机译:在阿尔茨海默氏病神经影像学倡议(ADNI)数据库中,阿尔茨海默氏病的认知内在表型与危险的单核苷酸多态性的关联。
机译:血小板和血小板生成:魁北克血小板疾病与尿激酶纤溶酶原激活物基因(PLAU)相关并增加了巨核细胞中相关等位基因的表达
机译:纤溶酶原激活剂尿激酶(脓液)中的功能多态性与阿尔茨海默病有关